Middle East And Africa Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Middle East And Africa Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

ID: 3488 | Pages: 137 | October 2018 | Region: Middle East and Africa


Overview of the Market:
The Middle East and Africa Competent Cells Market is worth USD 0.16 billion in 2018 and estimated to grow at a CAGR of 6.9%, to reach USD 0.21 billion by 2023. The Middle East and Africa Competent Cells market is developing at an exceptionally quick pace.

E. coli cells are more likely to incorporate exterior DNA if their cell walls are changed so that DNA can badge through more easily. In genetics, and molecular biology, competence is the ability of a cell to take up extracellular (isolated) DNA from its surroundings in the procedure called transformation. Cells are made competent by a technique that uses calcium chloride and high temperature shock.

Expansions in molecular cloning study due to the arrival of new technologies and the increasing commercial demand for molecular cloned products and recombinant proteins are some the key factors driving the growth of this market. However, growing market consolidation creating strong entry barriers and high cost of competent cells kits are curbing the growth of this market.

The Middle East and Africa market for Competent Cells is segmented on the basis of type, application, end user and region. Based on type, the market is segmented into Chemically, Electrocompetent. Based on application, the market is segmented into Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, and Mutagenesis. The chemically competent cells segment is expected to dominate the market in 2016. Cloning is estimated to command the major share of this market in 2017. Increasing study on cloning, driven by government funding is among the major reasons driving market growth in this segment. Based on end user, the market is segmented into Pharmaceutical Companies, Academia. Cloning is estimated to command the major share of this market in 2017. Increasing study on cloning, driven by government funding is among the major reasons driving market growth in this segment. In 2016, the academic research institutes segment is likely to have for the largest share of the market.

Geographical Analysis: 
Geographically, market is further segmented into Middle East and Africa. Middle East and Africa has an untapped market and key players are slowly expanding to this region which is the main reason for the growth of market in this region.

Key Players in this Market: 
BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan),  Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.),  Bioline (U.K.), Zymo Research (U.S.),are the leaders in the Middle East and Africa Competent Cells market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Chemically               

                                5.1.2 Electrocompetent

                                5.1.3  Y-o-Y Growth Analysis, By Type    

                                5.1.4  Market Attractiveness Analysis, By Type  

                                5.1.5  Market Share Analysis, ByType     

                5.2 Application                 

                                5.2.1 Cloning     

                                                5.2.1.1  Subcloning & Routine Cloning

                                                5.2.1.2 Phage Display Library Construction

                                                5.2.1.3 Toxic/Unstable Dna Cloning

                                                5.2.1.4 High-Throughput Cloning

                                5.2.2 Protein Expression              

                                5.2.3 Other Applications               

                                                5.2.3.1 Mutagenesis

                                                5.2.3.2 Large Plasmid Transformation

                                                5.2.3.4 Single-Stranded Dna Production

                                                5.2.3.5 Lentiviral Vector Production

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8  Market Attractiveness Analysis, By Application      

                                5.2.9  Market Share Analysis, By Application       

                5.3 End User                      

                                5.3.1 Pharmaceutical Companies              

                                5.3.2 Academia

                                5.3.3 Y-o-Y Growth Analysis, By EndUser              

                                5.3.4  Market Attractiveness Analysis, By EndUser           

                                5.3.5  Market Share Analysis, By EndUser             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Application

                                                6.1.3.4 By EndUser

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Application

                                                6.1.4.4 By EndUser

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Application

                                                6.1.5.4 By EndUser

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 BioDynamics Laboratory, Inc. (Japan)                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GCC Biotech (India)                 

                8.3 SMOBIO Technology (Taiwan)                            

                8.4 Thermo Fisher Scientific, Inc. (U.S)                   

                8.5 QIAGEN N.V. (Germany)                      

                8.6 OriGene Technologies (U.S.)                              

                8.7 Merck KGaA (Germany)                       

                8.8 Promega Corporation (U.S.)                

                8.9 Bioline (U.K.)                             

                8.10 Zymo Research (U.S.)                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Competent cells Market By Type, From 2018-2023 ( USD Million )
  2. Middle East & Africa Chemically Market By Region, From 2018-2023 ( USD Million )
  3. Middle East & Africa Electro Competent Market By Region, From 2018-2023 ( USD Million )
  4. Middle East & Africa Competent cells Market By Application, From 2018-2023 ( USD Million )
  5. Middle East & Africa SubCloning Market By Region, From 2018-2023 ( USD Million )
  6. Middle East & Africa Phage Display Library Production Market By Region, From 2018-2023 ( USD Million )
  7. Middle East & Africa Unstable DNA Cloning Market By Region, From 2018-2023 ( USD Million )
  8. Middle East & Africa High-Throughput Cloning Market By Region, From 2018-2023 ( USD Million )
  9. Middle East & Africa  Mutagenesis Market By Region, From 2018-2023 ( USD Million )
  10. Middle East & Africa Competent cells Market By End User, From 2018-2023 ( USD Million )
  11. Middle East & Africa Pharmaceutical Companies Market By Region, From 2018-2023 ( USD Million )
  12. Middle East & Africa Academia Market By Region, From 2018-2023 ( USD Million )
  13. Middle East Competent cells Market By Type, From 2018-2023 ( USD Million )
  14. Middle East Competent cells Market By Application, From 2018-2023 ( USD Million )
  15. Middle East Competent cells Market By End User, From 2018-2023 ( USD Million )
  16. Africa Competent cells Market By Type, From 2018-2023 ( USD Million )
  17. Africa Competent cells Market By Application, From 2018-2023 ( USD Million )
  18. Africa Competent cells Market By End User, From 2018-2023 ( USD Million )
Membranes Market By Type (Polymeric, Ceramics And Others), Technology (RO, UF, MF, NF, Pervaporation, Gas Separation And Others), Application (Water & Wastewater Treatment, Food & Beverage, Medical & Pharmaceutical,...
Latin America Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lun...
Asia Pacific Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lung...
Europe Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lung Cance...
North America Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lun...
Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lung Cancer, Othe...
Middle East And Africa Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Pr...
Latin America Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (in...
Asia-Pacific Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (ins...
Europe Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (instrumen...
North-America Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (in...
Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (instruments, Ana...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.